| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
Department of Primary Care and General Practice, Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
Correspondence to:
Dr D A Fitzmaurice, Department of Primary Care and General Practice, Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK;
D.A.Fitzmaurice{at}bham.ac.uk
Background: The increase in numbers of patients receiving warfarin treatment has led to the development of alternative models of service delivery for oral anticoagulant monitoring. Patient self management for oral anticoagulation is a model new to the UK. This randomised trial was the first to compare routine primary care management of oral anticoagulation with patient self management.
Aim: To test whether patient self management is as safe, in terms of clinical effectiveness, as primary care management within the UK, as assessed by therapeutic international normalised ratio (INR) control.
Method: Patients receiving warfarin from six general practices who satisfied study entry criteria were eligible to enter the study. Eligible patients were randomised to either intervention (patient self management) or control (routine primary care management) for six months. The intervention comprised two training sessions of one to two hours duration. Patients were allowed to undertake patient self management on successful completion of training. INR testing was undertaken using a Coaguchek device and regular internal/external quality control tests were performed. Patients were advised to perform INR tests every two weeks, or weekly if a dose adjustment was made. Dosage adjustment was undertaken using a simple dosing algorithm.
Results: Seventy eight of 206 (38%) patients were eligible for inclusion and, of these, 35 (45%) declined involvement or withdrew from the study. Altogether, 23 intervention and 26 control patients entered the study. There were no significant differences in INR control (per cent time in range: intervention, 74%; control, 77%). There were no serious adverse events in the intervention group, with one fatal retroperitoneal haemorrhage in the control group. Costs of patient self management were significantly greater than for routine care (£90 v £425/patient/year).
Conclusion: These are the first UK data to demonstrate that patient self management is as safe as primary care management for a selected population. Further studies are needed to elucidate whether this model of care is suitable for a larger population.
Keywords: oral anticoagulation; patient self management; primary care
Abbreviations: CRF, clinical report form; EQA, external quality assurance; INR, international normalised ratio; IQC, internal quality control
This article has been cited by other articles:
|
|
 |
|
  J. Ansell, J. Hirsh, E. Hylek, A. Jacobson, M. Crowther, and G. Palareti Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 160S - 198S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Franke, L. M. Dickerson, and P. J. Carek Improving Anticoagulation Therapy Using Point-of-Care Testing and a Standardized Protocol Ann. Fam. Med, January 1, 2008; 6(suppl_1): S28 - S32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W S A Smellie, K K Hampton, R Bowlees, S C Martin, N Shaw, J Hoffman, J P Ng, S M Mackenzie, and C van Heyningen Best practice in primary care pathology: review 8 J. Clin. Pathol., July 1, 2007; 60(7): 740 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Regier, R. Sunderji, L. D. Lynd, K. Gin, and C. A. Marra Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. Can. Med. Assoc. J., June 20, 2006; 174(13): 1847 - 1852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. van Walraven, A. Jennings, N. Oake, D. Fergusson, and A. J. Forster Effect of Study Setting on Anticoagulation Control: A Systematic Review and Metaregression Chest, May 1, 2006; 129(5): 1155 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D A Fitzmaurice, E T Murray, D McCahon, R Holder, J P Raftery, S Hussain, H Sandhar, and F D R Hobbs Self management of oral anticoagulation: randomised trial BMJ, November 5, 2005; 331(7524): 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S.J. Miller, M. F. Drummond, L. K. Langkilde, J. J.V. McMurray, and M. Ogren Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C41 - C54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Menendez-Jandula, J. C. Souto, A. Oliver, I. Montserrat, M. Quintana, I. Gich, X. Bonfill, and J. Fontcuberta Comparing Self-Management of Oral Anticoagulant Therapy with Clinic Management: A Randomized Trial Ann Intern Med, January 4, 2005; 142(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kagansky, H. Knobler, E. Rimon, Z. Ozer, and S. Levy Safety of Anticoagulation Therapy in Well-informed Older Patients Arch Intern Med, October 11, 2004; 164(18): 2044 - 2050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Schunemann, D. Cook, J. Grimshaw, A. Liberati, J. Heffner, V. Tapson, and G. Guyatt Antithrombotic and Thrombolytic Therapy: From Evidence to Application: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 688S - 696S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Vincze and A. Parthan The Value of Home Monitoring Kits in Diabetes, Hypertension, Asthma, and Oral Anticoagulation Therapy Journal of Pharmacy Practice, June 1, 2004; 17(3): 182 - 196. [Abstract] [PDF]
|
|
|
|
|
|
E. Murray, D. Fitzmaurice, D. McCahon, C. Fuller, and H. Sandhur Training for patients in a randomised controlled trial of self management of warfarin treatment BMJ, February 21, 2004; 328(7437): 437 - 438. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Vink, R. A. Kraaijenhagen, B. A. Hutten, R. B. A. van den Brink, B. A. de Mol, H. R. Buller, and M. Levi The optimal intensity of vitamin k antagonists in patients with mechanical heart valves: A meta-analysis J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2042 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Murray and M Greaves INRs and point of care testing BMJ, July 3, 2003; 327(7405): 5 - 6. [Full Text] [PDF]
|
|
|
|
|
|
L. Poller, M. Keown, N. Chauhan, A. M. van den Besselaar, A. Tripodi, C. Shiach, and J. Jespersen Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods BMJ, July 3, 2003; 327(7405): 30. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |
